[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Compounding Pharmacy Industry Research Report 2024

February 2024 | 115 pages | ID: C6460D63E10FEN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report aims to provide a comprehensive presentation of the global market for Compounding Pharmacy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Compounding Pharmacy.

The Compounding Pharmacy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Compounding Pharmacy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Compounding Pharmacy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • PharMEDium Services
  • B. Braun Group
  • Fagron
  • Wedgewood Pharmacy
  • New Compounding Pharma
  • Medisca
  • Fresenius Kabi
  • Advanced Pharma
  • AIN GROUP
  • Nihon Chouzai
  • Sogo Medical
  • Dougherty’s Pharmacy
  • Apollo Pharmacy
  • Downing Labs
  • Qol Holdings
  • Olympia Pharmacy
  • PUMCH
  • Triangle Compounding Pharmacy
  • Peking University First Hospital
  • Affiliated Hospital of Guangdong Public Institution of Medicine
  • Lorraine's Pharmacy
  • PLAGH
  • Institutional Pharmacy Solutions
  • Ruijin Hospital
  • Belle Sante
  • Byculla Pharmacy&Stores
  • Royal Chemists
  • Village Compounding Pharmacy
  • Specialist Pharmacy
Product Type Insights

Global markets are presented by Compounding Pharmacy type, along with growth forecasts through 2030. Estimates on revenue are based on the price in the supply chain at which the Compounding Pharmacy are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2019-2024) and forecast period (2025-2030).

Compounding Pharmacy segment by Type
  • PIA
  • PAA
  • CUPM
  • PDA
  • SAPM
Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2019-2024) and forecast period (2025-2030).

This report also outlines the market trends of each segment and consumer behaviors impacting the Compounding Pharmacy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Compounding Pharmacy market.

Compounding Pharmacy Segment by Application
  • Consumers Aged 18 and Younger
  • Consumers Aged 19 to 44
  • Consumers Aged 45 to 64
  • Consumers Aged 65 and Older
Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2019-2030.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2023 because of the base year, with estimates for 2024 and forecast revenue for 2030.
  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Nordic Countries
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Compounding Pharmacy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Compounding Pharmacy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Compounding Pharmacy and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Compounding Pharmacy industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Compounding Pharmacy.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Core Chapters

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Compounding Pharmacy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Compounding Pharmacy by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030)
  1.2.2 PIA
  1.2.3 PAA
  1.2.4 CUPM
  1.2.5 PDA
  1.2.6 SAPM
2.3 Compounding Pharmacy by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030)
  2.3.2 Consumers Aged 18 and Younger
  2.3.3 Consumers Aged 19 to
  2.3.4 Consumers Aged 45 to
  2.3.5 Consumers Aged 65 and Older
2.4 Assumptions and Limitations

3 COMPOUNDING PHARMACY BREAKDOWN DATA BY TYPE

3.1 Global Compounding Pharmacy Historic Market Size by Type (2019-2024)
3.2 Global Compounding Pharmacy Forecasted Market Size by Type (2025-2030)

4 COMPOUNDING PHARMACY BREAKDOWN DATA BY APPLICATION

4.1 Global Compounding Pharmacy Historic Market Size by Application (2019-2024)
4.2 Global Compounding Pharmacy Forecasted Market Size by Application (2019-2024)

5 GLOBAL GROWTH TRENDS

5.1 Global Compounding Pharmacy Market Perspective (2019-2030)
5.2 Global Compounding Pharmacy Growth Trends by Region
  5.2.1 Global Compounding Pharmacy Market Size by Region: 2019 VS 2023 VS 2030
  5.2.2 Compounding Pharmacy Historic Market Size by Region (2019-2024)
  5.2.3 Compounding Pharmacy Forecasted Market Size by Region (2025-2030)
5.3 Compounding Pharmacy Market Dynamics
  5.3.1 Compounding Pharmacy Industry Trends
  5.3.2 Compounding Pharmacy Market Drivers
  5.3.3 Compounding Pharmacy Market Challenges
  5.3.4 Compounding Pharmacy Market Restraints

6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS

6.1 Global Top Compounding Pharmacy Players by Revenue
  6.1.1 Global Top Compounding Pharmacy Players by Revenue (2019-2024)
  6.1.2 Global Compounding Pharmacy Revenue Market Share by Players (2019-2024)
6.2 Global Compounding Pharmacy Industry Players Ranking, 2022 VS 2023 VS 2024
6.3 Global Key Players of Compounding Pharmacy Head office and Area Served
6.4 Global Compounding Pharmacy Players, Product Type & Application
6.5 Global Compounding Pharmacy Players, Date of Enter into This Industry
6.6 Global Compounding Pharmacy Market CR5 and HHI
6.7 Global Players Mergers & Acquisition

7 NORTH AMERICA

7.1 North America Compounding Pharmacy Market Size (2019-2030)
7.2 North America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 North America Compounding Pharmacy Market Size by Country (2019-2024)
7.4 North America Compounding Pharmacy Market Size by Country (2025-2030)
7.5 United States
7.6 Canada

8 EUROPE

8.1 Europe Compounding Pharmacy Market Size (2019-2030)
8.2 Europe Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Europe Compounding Pharmacy Market Size by Country (2019-2024)
8.4 Europe Compounding Pharmacy Market Size by Country (2025-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries

9 ASIA-PACIFIC

9.1 Asia-Pacific Compounding Pharmacy Market Size (2019-2030)
9.2 Asia-Pacific Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Asia-Pacific Compounding Pharmacy Market Size by Country (2019-2024)
9.4 Asia-Pacific Compounding Pharmacy Market Size by Country (2025-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia

10 LATIN AMERICA

10.1 Latin America Compounding Pharmacy Market Size (2019-2030)
10.2 Latin America Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Latin America Compounding Pharmacy Market Size by Country (2019-2024)
10.4 Latin America Compounding Pharmacy Market Size by Country (2025-2030)
9.4 Mexico
9.5 Brazil

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Compounding Pharmacy Market Size (2019-2030)
11.2 Middle East & Africa Compounding Pharmacy Market Growth Rate by Country: 2019 VS 2023 VS 2030
11.3 Middle East & Africa Compounding Pharmacy Market Size by Country (2019-2024)
11.4 Middle East & Africa Compounding Pharmacy Market Size by Country (2025-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE

12 PLAYERS PROFILED

11.1 PharMEDium Services
  11.1.1 PharMEDium Services Company Detail
  11.1.2 PharMEDium Services Business Overview
  11.1.3 PharMEDium Services Compounding Pharmacy Introduction
  11.1.4 PharMEDium Services Revenue in Compounding Pharmacy Business (2017-2022)
  11.1.5 PharMEDium Services Recent Development
11.2 B. Braun Group
  11.2.1 B. Braun Group Company Detail
  11.2.2 B. Braun Group Business Overview
  11.2.3 B. Braun Group Compounding Pharmacy Introduction
  11.2.4 B. Braun Group Revenue in Compounding Pharmacy Business (2017-2022)
  11.2.5 B. Braun Group Recent Development
11.3 Fagron
  11.3.1 Fagron Company Detail
  11.3.2 Fagron Business Overview
  11.3.3 Fagron Compounding Pharmacy Introduction
  11.3.4 Fagron Revenue in Compounding Pharmacy Business (2017-2022)
  11.3.5 Fagron Recent Development
11.4 Wedgewood Pharmacy
  11.4.1 Wedgewood Pharmacy Company Detail
  11.4.2 Wedgewood Pharmacy Business Overview
  11.4.3 Wedgewood Pharmacy Compounding Pharmacy Introduction
  11.4.4 Wedgewood Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.4.5 Wedgewood Pharmacy Recent Development
11.5 New Compounding Pharma
  11.5.1 New Compounding Pharma Company Detail
  11.5.2 New Compounding Pharma Business Overview
  11.5.3 New Compounding Pharma Compounding Pharmacy Introduction
  11.5.4 New Compounding Pharma Revenue in Compounding Pharmacy Business (2017-2022)
  11.5.5 New Compounding Pharma Recent Development
11.6 Medisca
  11.6.1 Medisca Company Detail
  11.6.2 Medisca Business Overview
  11.6.3 Medisca Compounding Pharmacy Introduction
  11.6.4 Medisca Revenue in Compounding Pharmacy Business (2017-2022)
  11.6.5 Medisca Recent Development
11.7 Fresenius Kabi
  11.7.1 Fresenius Kabi Company Detail
  11.7.2 Fresenius Kabi Business Overview
  11.7.3 Fresenius Kabi Compounding Pharmacy Introduction
  11.7.4 Fresenius Kabi Revenue in Compounding Pharmacy Business (2017-2022)
  11.7.5 Fresenius Kabi Recent Development
11.8 Advanced Pharma
  11.8.1 Advanced Pharma Company Detail
  11.8.2 Advanced Pharma Business Overview
  11.8.3 Advanced Pharma Compounding Pharmacy Introduction
  11.8.4 Advanced Pharma Revenue in Compounding Pharmacy Business (2017-2022)
  11.8.5 Advanced Pharma Recent Development
11.9 AIN GROUP
  11.9.1 AIN GROUP Company Detail
  11.9.2 AIN GROUP Business Overview
  11.9.3 AIN GROUP Compounding Pharmacy Introduction
  11.9.4 AIN GROUP Revenue in Compounding Pharmacy Business (2017-2022)
  11.9.5 AIN GROUP Recent Development
11.10 Nihon Chouzai
  11.10.1 Nihon Chouzai Company Detail
  11.10.2 Nihon Chouzai Business Overview
  11.10.3 Nihon Chouzai Compounding Pharmacy Introduction
  11.10.4 Nihon Chouzai Revenue in Compounding Pharmacy Business (2017-2022)
  11.10.5 Nihon Chouzai Recent Development
11.11 Sogo Medical
  11.11.1 Sogo Medical Company Detail
  11.11.2 Sogo Medical Business Overview
  11.11.3 Sogo Medical Compounding Pharmacy Introduction
  11.11.4 Sogo Medical Revenue in Compounding Pharmacy Business (2017-2022)
  11.11.5 Sogo Medical Recent Development
11.12 Dougherty’s Pharmacy
  11.12.1 Dougherty’s Pharmacy Company Detail
  11.12.2 Dougherty’s Pharmacy Business Overview
  11.12.3 Dougherty’s Pharmacy Compounding Pharmacy Introduction
  11.12.4 Dougherty’s Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.12.5 Dougherty’s Pharmacy Recent Development
11.13 Apollo Pharmacy
  11.13.1 Apollo Pharmacy Company Detail
  11.13.2 Apollo Pharmacy Business Overview
  11.13.3 Apollo Pharmacy Compounding Pharmacy Introduction
  11.13.4 Apollo Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.13.5 Apollo Pharmacy Recent Development
11.14 Downing Labs
  11.14.1 Downing Labs Company Detail
  11.14.2 Downing Labs Business Overview
  11.14.3 Downing Labs Compounding Pharmacy Introduction
  11.14.4 Downing Labs Revenue in Compounding Pharmacy Business (2017-2022)
  11.14.5 Downing Labs Recent Development
11.15 Qol Holdings
  11.15.1 Qol Holdings Company Detail
  11.15.2 Qol Holdings Business Overview
  11.15.3 Qol Holdings Compounding Pharmacy Introduction
  11.15.4 Qol Holdings Revenue in Compounding Pharmacy Business (2017-2022)
  11.15.5 Qol Holdings Recent Development
11.16 Olympia Pharmacy
  11.16.1 Olympia Pharmacy Company Detail
  11.16.2 Olympia Pharmacy Business Overview
  11.16.3 Olympia Pharmacy Compounding Pharmacy Introduction
  11.16.4 Olympia Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.16.5 Olympia Pharmacy Recent Development
11.17 PUMCH
  11.17.1 PUMCH Company Detail
  11.17.2 PUMCH Business Overview
  11.17.3 PUMCH Compounding Pharmacy Introduction
  11.17.4 PUMCH Revenue in Compounding Pharmacy Business (2017-2022)
  11.17.5 PUMCH Recent Development
11.18 Triangle Compounding Pharmacy
  11.18.1 Triangle Compounding Pharmacy Company Detail
  11.18.2 Triangle Compounding Pharmacy Business Overview
  11.18.3 Triangle Compounding Pharmacy Compounding Pharmacy Introduction
  11.18.4 Triangle Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.18.5 Triangle Compounding Pharmacy Recent Development
11.19 Peking University First Hospital
  11.19.1 Peking University First Hospital Company Detail
  11.19.2 Peking University First Hospital Business Overview
  11.19.3 Peking University First Hospital Compounding Pharmacy Introduction
  11.19.4 Peking University First Hospital Revenue in Compounding Pharmacy Business (2017-2022)
  11.19.5 Peking University First Hospital Recent Development
11.20 Affiliated Hospital of Guangdong Public Institution of Medicine
  11.20.1 Affiliated Hospital of Guangdong Public Institution of Medicine Company Detail
  11.20.2 Affiliated Hospital of Guangdong Public Institution of Medicine Business Overview
  11.20.3 Affiliated Hospital of Guangdong Public Institution of Medicine Compounding Pharmacy Introduction
  11.20.4 Affiliated Hospital of Guangdong Public Institution of Medicine Revenue in Compounding Pharmacy Business (2017-2022)
  11.20.5 Affiliated Hospital of Guangdong Public Institution of Medicine Recent Development
11.21 Lorraine's Pharmacy
  11.21.1 Lorraine's Pharmacy Company Detail
  11.21.2 Lorraine's Pharmacy Business Overview
  11.21.3 Lorraine's Pharmacy Compounding Pharmacy Introduction
  11.21.4 Lorraine's Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.21.5 Lorraine's Pharmacy Recent Development
11.22 PLAGH
  11.22.1 PLAGH Company Detail
  11.22.2 PLAGH Business Overview
  11.22.3 PLAGH Compounding Pharmacy Introduction
  11.22.4 PLAGH Revenue in Compounding Pharmacy Business (2017-2022)
  11.22.5 PLAGH Recent Development
11.23 Institutional Pharmacy Solutions
  11.23.1 Institutional Pharmacy Solutions Company Detail
  11.23.2 Institutional Pharmacy Solutions Business Overview
  11.23.3 Institutional Pharmacy Solutions Compounding Pharmacy Introduction
  11.23.4 Institutional Pharmacy Solutions Revenue in Compounding Pharmacy Business (2017-2022)
  11.23.5 Institutional Pharmacy Solutions Recent Development
11.24 Ruijin Hospital
  11.24.1 Ruijin Hospital Company Detail
  11.24.2 Ruijin Hospital Business Overview
  11.24.3 Ruijin Hospital Compounding Pharmacy Introduction
  11.24.4 Ruijin Hospital Revenue in Compounding Pharmacy Business (2017-2022)
  11.24.5 Ruijin Hospital Recent Development
11.25 Belle Sante
  11.25.1 Belle Sante Company Detail
  11.25.2 Belle Sante Business Overview
  11.25.3 Belle Sante Compounding Pharmacy Introduction
  11.25.4 Belle Sante Revenue in Compounding Pharmacy Business (2017-2022)
  11.25.5 Belle Sante Recent Development
11.26 Byculla Pharmacy&Stores
  11.26.1 Byculla Pharmacy&Stores Company Detail
  11.26.2 Byculla Pharmacy&Stores Business Overview
  11.26.3 Byculla Pharmacy&Stores Compounding Pharmacy Introduction
  11.26.4 Byculla Pharmacy&Stores Revenue in Compounding Pharmacy Business (2017-2022)
  11.26.5 Byculla Pharmacy&Stores Recent Development
11.27 Royal Chemists
  11.27.1 Royal Chemists Company Detail
  11.27.2 Royal Chemists Business Overview
  11.27.3 Royal Chemists Compounding Pharmacy Introduction
  11.27.4 Royal Chemists Revenue in Compounding Pharmacy Business (2017-2022)
  11.27.5 Royal Chemists Recent Development
11.28 Village Compounding Pharmacy
  11.28.1 Village Compounding Pharmacy Company Detail
  11.28.2 Village Compounding Pharmacy Business Overview
  11.28.3 Village Compounding Pharmacy Compounding Pharmacy Introduction
  11.28.4 Village Compounding Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.28.5 Village Compounding Pharmacy Recent Development
11.29 Specialist Pharmacy
  11.29.1 Specialist Pharmacy Company Detail
  11.29.2 Specialist Pharmacy Business Overview
  11.29.3 Specialist Pharmacy Compounding Pharmacy Introduction
  11.29.4 Specialist Pharmacy Revenue in Compounding Pharmacy Business (2017-2022)
  11.29.5 Specialist Pharmacy Recent Development

13 REPORT CONCLUSION

14 DISCLAIMER



More Publications